OSCR
Oscar Health, Inc.
OSCR has a slight edge over WRBY overall, supported by stronger fundamentals.
WRBY
Warby Parker Inc.
WRBY has lower modeled downside risk, despite its lower overall score.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
WRBY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
WRBY's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over WRBY in the historical PE scenario, which offers more potential upside but is not a forecast.
WRBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 53x | $26.73 | — |
| Cheap | 439x | $21.93 | -18% |
| Current | 535x | $26.73 | — |
| Fair | 2,274x | $114 | +325% |
| Expensive | 2,646x | $132 | +395% |
Historical ranges are pointers, not guarantees.
WRBY's PE is in its cheap range at 535x. If earnings grow as analysts expect, today's price would be 53x next year's earnings.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
WRBY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for WRBY, with profitability improving. However, they disagree widely on these estimates.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
WRBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | +916% |
| Q3 2026 | $0.05 | +400% |
| Q2 2026 | $0.06 | +$0.13 |
| Q1 2026 | $0.01 | +$0.13 |
| Q4 2025 | $0.01 | +$0.18 |
| Q3 2025 | $0.01 | +$0.28 |
| Q2 2025 | -$0.07 | +$0.32 |
| Q1 2025 | -$0.12 | +$0.35 |
| Q4 2024 | -$0.17 | +$0.37 |
WRBY has the edge over OSCR on earnings, with more consistent year-over-year improvement.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over WRBY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over WRBY on profitability, with a higher operating margin.
WRBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.7M | +10% |
| Q2 2026 | $235.5M | +9.8% |
| Q1 2026 | $242.4M | +8.3% |
| Q4 2025 | $212M | +11% |
| Q3 2025 | $221.7M | +15% |
| Q2 2025 | $214.5M | +14% |
| Q1 2025 | $223.8M | +12% |
| Q4 2024 | $190.6M | +18% |
WRBY's revenue has grown year over year every quarter since early 2021: $245M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | -0.2 points |
| Q2 2026 | 1.3% | +3.5 points |
| Q1 2026 | 0.7% | -0.4 points |
| Q4 2025 | -3.2% | +1.7 points |
| Q3 2025 | 1.6% | +5 points |
| Q2 2025 | -2.1% | +2.6 points |
| Q1 2025 | 1.1% | +3.7 points |
| Q4 2024 | -4.9% | +8.4 points |
WRBY's operating margin was 1.4% last quarter, about level with the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over WRBY on cash flow, with more consistent year-over-year improvement.
WRBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2M | -$459K |
| Q2 2026 | $6.8M | -72% |
| Q1 2026 | $8.4M | -37% |
| Q4 2025 | $8.1M | +271% |
| Q3 2025 | -$1.5M | -112% |
| Q2 2025 | $23.9M | +71% |
| Q1 2025 | $13.2M | +141% |
| Q4 2024 | $2.2M | +2282% |
WRBY usually generates cash, though not every quarter: the latest was −$2M, but it generated $21M over the past year.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
WRBY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +401K shares |
| 1 year | +0.6% | +741K shares |
| 3 years | +6.9% | +8.1M shares |
| 5 years | +101% | +63.3M shares |
WRBY has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | $2M |
| Q1 2021 | $6.1M |
| Q4 2020 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
WRBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.1x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -9.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -16.1x | Net Cash |
WRBY has the edge over OSCR on leverage, with a lower net debt burden relative to earnings.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
WRBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 40.8 | Neutral |
WRBY's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over WRBY on valuation relative to its sector.
WRBY PE vs Healthcare Sector
| Metric | WRBY | Sector median | Relative |
|---|---|---|---|
| PE | 535x | 26x | 1,968% above |
| PE % | 26 | 39 | 13 pts below |
WRBY is trading at 535x earnings, a 1968% premium to the Healthcare sector's median of 26x.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR is in an uptrend: it's above all five of its weekly moving averages, and 106% above its 200-week average.
WRBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 4.3% above |
| 20 week MA | $25.9 | 3.3% above |
| 50 week MA | $25.2 | 6.2% above |
| 100 week MA | $23.7 | 13% above |
| 200 week MA | $18.9 | 42% above |
WRBY is in an uptrend: it's above all five of its weekly moving averages, and 42% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over WRBY on returns for 2026, with the stronger performance.
WRBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.7 | $47.5 | -12% |
| 2022 | $47.5 | $13.5 | -72% |
| 2023 | $13.5 | $14.1 | +4.2% |
| 2024 | $14.1 | $24.4 | +73% |
| 2025 | $24.4 | $24.2 | -1% |
| 2026 YTD | $24.2 | $26.7 | +11% |
WRBY has finished lower in three of the last five years. It's up 11% so far in 2026.